Researchers say semaglutide, the medication in Ozempic and Wegovy, may help reverse MASH, a progressive liver condition ...

A study published in the Journal of Hepatology found that simultaneous bariatric surgery and liver transplant for severely obese patients is safe and improves long-term health outcomes. Here are five ...

A late-stage clinical study showed that this weight loss drug helped 2 out of 3 people with the life-threatening liver ...

There is no standard of care for fibrolamellar liver cancer, no targeted therapies. But that may be changing, thanks to recent findings by rare cancer researcher Dr. Taran Gujral, head of Fred Hutch's ...

The Italian study showed that patients with HCC resulting from viral infections or fatty liver had significantly higher ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

Metabolic liver disease might not get as much attention as heart disease or diabetes, but it affects around one in four people worldwide. Once called non-alcoholic fatty liver disease, this condition ...

The cutting-edge weight-loss drug Ozempic/Wegovy can stop and even reverse fatty liver disease, a new clinical trial has ...

A study from the New England Journal of Medicine found new evidence that GLP-1 drugs used for diabetes and obesity could also ...